Up | AC
Home Page
Food and
Drug Administration
Cellular, Tissue and Gene Therapies Advisory Committee
May 14-15, 2009
BRIEFING INFORMATION
Topic I
FDA
Potential for Chlamydia trachomatis and Neisseria gonorrhoeae transmission by human cells, tissues, and cellular and tissue-based products (HCT/Ps) that are recovered from the reproductive system, gestational tissues, or other sources. ( htm)
Bibliography (htm)
Topic II
FDA
Animal Models for Porcine Xenotransplantation Products Intended to Treat
Type 1 Diabetes or Acute Liver Failure (htm)
Bibliography (htm)
Topic III
FDA
Clinical issues related to the FDA draft guidance “Preparation of IDEs and INDs for Products Intended to Repair or Replace Knee Cartilage” (pdf)